Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Insulet Corporation (PODD) trades at a P/E ratio of 26.4×. Over the past ten years it has ranged from 0.0× (December 2021) to 33,023× (May 2023); the current reading is higher than 39% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 81.2× 86.02%
FY2024 43.7× (38.41%)
FY2023 70.9× (98.27%)
FY2022 4,091× 253.65%
FY2021 1,157× (50.22%)
FY2020 2,324× 144.34%
FY2019 951× (28.06%)
FY2018 1,322× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 28.5× (41.68%)
Mar 2026 48.8× (39.91%)
Dec 2025 81.2× (7.93%)
Sep 2025 88.2× (5.38%)
42 more quarters

Against its own ten years

Low 0.0× High 33,023×
Ten-year median 47.7×
Current reading's percentile 2

P/E ratio against peers

Company P/E ratio
BRKR Bruker Corporation compare n/m
GKOS Glaukos Corporation compare n/m
GMED Globus Medical, Inc. compare 19.3×
PODD Insulet Corporation 26.4×
SNN Smith & Nephew SNATS, Inc. compare 35.4×
BIO Bio-Rad Laboratories, Inc. compare 42.5×
BIO.B Bio-Rad Laboratories, Inc. compare 43.7×
HAE Haemonetics Corporation compare 57.7×
PEN Penumbra, Inc. compare 78.4×
Medical Devices industry median 23.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PODD